vanbeekdulejos1771.blogspot.com
The Miami-based biotechnology developmentcompany OPK) is looking for money to support clinicap trials in the ophthalmology field. “We are pleasedr to receive these funds and appreciate the confidence of the investorsin Opko’ws future success,” Opko Chairman and CEO Dr. Philliop Frost said in a news release. Thred entities controlled by Taiwan-based Ruentex Group Chung Chia Co. Ltd., Grandtime Associates Ltd. and Gold Sino Assetse Ltd. – invested a combinesd $20 million in Opko. Ruentex’s operations include textiles, construction and development, medical services, retail and Miami-based tobacco company (NYSE: VGR) invested $5 milliomn in Opko.
Frost beneficialluy owns 11.5 percent of Vector Group, Opko stated in a filinfg on Monday. Two groups controlled by Greenwich, Conn.-based Oracle Partners, one of the world’s biggest healthg care focusedhedge funds, invested a combined $5 millio n in Opko. The remaining $1 million came from Nora Real which is controlled by former directorCarl Salvi. Frost got a spot on Teva’e board after the Israeli company acquiredhis Miami-based Opko sharezs were up 7 cents to $1.27 in morning No high/low information was available.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment